Skip to content Inauguração emGrand opening inInauguración en --d --h --m --s · Cadastro VIP ›· VIP sign-up ›· Registro VIP › Abrimos hoje · aguardeWe open today · hold onAbrimos hoy · aguarde Loja aberta! Entrar ›Store open! Enter ›¡Tienda abierta! Entrar ›

KNOWLEDGE · COMPOUNDS

Follistatin

Also known as: Folistatin 344 · follistatin-344

MusclePreclinicalPubMed records: 50count from PubMed, not curated

Overview

A Folistatina 344 é uma glicoproteína endógena de 344 aminoácidos que funciona como um inibidor natural da miostatina e das ativinas. No contexto de pesquisa com peptídeos, é utilizada como agente anti-miostatina para promover crescimento muscular além do limite genético natural. Diferente do ACE-031, a folistatina é uma molécula endógena com papel fisiológico estabelecido, mas os dados de uso exógeno em humanos são muito limitados. Original in PT-BR

Follistatin is catalogued under Muscle. 22 Eagle articles in this library reference this compound.

Category
Muscle
Research stage
Preclinical — Pré-Clínico Original in PT-BR
PubMed records
50 (count from PubMed, not curated)
Eagle articles on this compound
22 Eagle articles

Mechanism

Glicoproteína de 344 aminoácidos — liga e neutraliza miostatina, ativina e FSH Original in PT-BR

A Folistatina 344 se liga com alta afinidade à miostatina (GDF-8), ativinas e outros membros da superfamília TGF-β, impedindo sua ligação aos receptores ActRIIB na superfície celular muscular. Ao neutralizar a miostatina, remove o sinal inibitório para o crescimento muscular. Também suprime FSH ao se ligar à ativina, o que pode afetar a função reprodutiva. Estudos de terapia gênica demonstraram hipertrofia muscular dramática em modelos animais com superexpressão de folistatina. Original in PT-BR

Eagle articles on this compound

Chemical information

CAS
80449-31-6
Molecular formula
Glicoproteína de 344 aminoácidos Original in PT-BR
Molecular weight
~38.000 Da (com glicosilação) Original in PT-BR
Sequence
Proteína de 344aa com 3 domínios follistatin-like Original in PT-BR
Amino acids
Not recorded in the source.
Solubility
Água bacteriostática, PBS Original in PT-BR
Stability
Liofilizado: -20°C. Reconstituído: 7 dias 2-8°C Original in PT-BR
Half-life
Curta (~horas) Original in PT-BR
Bioavailability
Variável (proteína grande) Original in PT-BR
Onset
2-4 semanas (hipertrofia) Original in PT-BR
Routes
SC

Research references

No individual dosing recommendation is given. Values are as recorded in the source, with species and route stated where known.

Third-party research score

40/ 100

Score assigned by the imported source, on its own scale and with no published methodology. Eagle does not compute it, does not verify it and does not endorse it. It appears here to preserve the record, not as an assessment.

  • Estabeleceu miostatina como regulador negativo central de massa muscular Original in PT-BR

    PMID: 11408472Year: 2001Species: Not recorded as a structured field in the source.Route: Not recorded as a structured field in the source.Duration: Not recorded as a structured field in the source.Purpose: Not recorded as a structured field in the source.
  • Terapia gênica com folistatina aumentou força e massa muscular em primatas Original in PT-BR

    PMID: 17293831Year: 2007Species: Not recorded as a structured field in the source.Route: Not recorded as a structured field in the source.Duration: Not recorded as a structured field in the source.Purpose: Not recorded as a structured field in the source.
  • Folistatina promoveu regeneração muscular e reduziu fibrose após lesão Original in PT-BR

    PMID: 27102983Year: 2016Species: Not recorded as a structured field in the source.Route: Not recorded as a structured field in the source.Duration: Not recorded as a structured field in the source.Purpose: Not recorded as a structured field in the source.

Safety

Commonly reported

  • Reações no local da injeção
  • Possível retenção hídrica

Serious

  • Supressão de FSH — pode afetar fertilidade
  • Dados humanos muito limitados para avaliar perfil de segurança

Contraindications

  • Planejamento de fertilidade (supressão FSH)
  • Cânceres hormônio-sensíveis

Warnings

  • Dados humanos extremamente limitados
  • Potencial impacto reprodutivo via supressão de FSH/ativina

Original in PT-BR — This text was written in Brazilian Portuguese and is shown as recorded. Open the PT-BR page for Follistatin.

Lab tests named in the source

  • FSH / LH
  • Hemograma completo
  • CK
  • Testosterona

The source names the tests and nothing else: no reference values and no thresholds. None were added here. Interpreting a result is a clinical act and is not offered on this page.

Reported protocols

Recorded in the imported source as community protocols. They are NOT Eagle protocols, were not reviewed by Eagle, and are not a dosing recommendation, a prescription or clinical guidance. Values appear exactly as recorded, in the language they were written in.

Dosing summary as recorded

Dose Pesquisada
100mcg/dia SC Original in PT-BR
Range
50-200mcg/dia Original in PT-BR
Dados
Muito limitados em humanos Original in PT-BR

Vial sizes: 1mg — Peptide Calculator

Interactions

These relations come from the imported reference material, which records one label and one comment per pair and no source: no PMID, no population or model, no evidence type and no degree of certainty. Eagle did not verify them and does not endorse them. «Compatible», «Caution» and «Avoid» are the imported material's wording, not an Eagle authorisation or prohibition, and none of this is medical advice.

Compatible

Caution

Related

View all (22)

← Back to knowledge area